Cited by 130Wnt/β-catenin signaling in development and cancerReceptor Mechanisms and SignalingColorectal Cancer Treatments and Studies

The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.

LGR6 Is a High Affinity Receptor of R-Spondins and Potentially Functions as a Tumor Suppressor

Open access

Abstract

BACKGROUND: LGR6 (leucine-rich repeat containing, G protein-coupled receptor 6) is a member of the rhodopsin-like seven transmembrane domain receptor superfamily with the highest homology to LGR4 and LGR5. LGR6 was found as one of the novel genes mutated in colon cancer through total exon sequencing and its promoter region is hypermethylated in 20-50% of colon cancer cases. In the skin, LGR6 marks a population of stem cells that can give rise to all cell lineages. Recently, we and others demonstrated that LGR4 and LGR5 function as receptors of R-spondins to potentiate Wnt/β-catenin signaling. However, the binding affinity and functional response of LGR6 to R-spondins, and the activity of colon cancer mutants of LGR6 have not been determined. PRINCIPAL FINDINGS: We found that LGR6 also binds and responds to R-spondins 1-3 with high affinity to enhance Wnt/β-catenin signaling through increased LRP6 phosphorylation. Similar to LGR4 and LGR5, LGR6 is not coupled to heterotrimeric G proteins or to β-arrestin following R-spondin stimulation. Functional and expression analysis of three somatic mutations identified in colon cancer samples indicates that one mutant fails to bind and respond to R-spondin (loss-of-function), but the other two have no significant effect on receptor function. Overexpression of wild-type LGR6 in HeLa cells leads to increased cell migration following co-treatment with R-spondin1 and Wnt3a when compared to vector control cells or cells overexpressing the loss-of-function mutant. CONCLUSIONS: LGR6 is a high affinity receptor for R-spondins 1-3 and potentially functions as a tumor suppressor despite its positive effect on Wnt/β-catenin signaling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0037137

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

1 of the 61 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Metadata

Authors
Gong, X., Carmon, K. S., Lin, Q., Thomas, A., Yi, J., & Liu, Q.
Affiliations
The University of Texas Health Science Center at Houston (US)
Corresponding author
Liu, Qingyun
Venue
PLoS ONE
Published
2012-05-17
Volume
7
Issue
5
Pages
e37137
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2110651281
Cited by
129
References
61
Citations by year
2026: 4 · 2025: 3 · 2024: 6 · 2023: 8 · 2022: 10 · 2021: 11 · 2020: 18 · 2019: 16 · 2018: 14 · 2017: 5 · 2016: 6 · 2015: 4 · 2014: 8 · 2013: 12 · 2012: 4
FWCI
3.60
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Cancer Prevention and Research Institute of Texas (RP100678)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Keywords
LGR6, R-spondin, Wnt/β-catenin signaling, LRP6 phosphorylation, colon cancer, tumor suppressor, loss-of-function mutations, cell migration, Wnt3a, G protein-coupled receptors, skin stem cells, promoter hypermethylation
MeSH terms
Cell Movement, Colonic Neoplasms, HeLa Cells, Humans, Mutation, Protein Binding, Signal Transduction, GTP-Binding Proteins, Thrombospondins, Tumor Suppressor Proteins, Intercellular Signaling Peptides and Proteins, Receptors, G-Protein-Coupled, Wnt Proteins, beta Catenin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review